Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Roberto Grandinetti

Biographic Data

ID6002325
NAMERoberto Grandinetti
GIVEN NAMESRoberto
FAMILY NAMEGrandinetti
SIGNATUREGRANDINETTI R
AFFILIATIONSUniversity of Padua
ORCID0000-0002-1341-761X
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS1
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2026
H-INDEX1
  • Phenotyping Pediatric Long Covid

    Open Access•Susanna Esposito, Giuseppe Maglietta et al.•ARTICLE•Children•2026

    Background: The aim of this study was to identify patient clusters based on acute symptom profiles and individual characteristics most likely to develop pediatric post-acute sequelae of SARS-CoV-2 infection (PASC), as well as clusters among patients with PASC based on post-acute sequelae and associated characteristics. Methods: This multicenter cohort study in 12 Italian pediatric units enrolled patients aged 0-17 years within three months of a l…

  • FLAIR Hyperintense Cortical Lesions in a 4-Year-Old Child with Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis and Seizures

    Open Access•Luca Bernardi, Nicole Mussi et al.•ARTICLE•Children•2024

    Myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease (MOGAD) is a relatively uncommon autoantibody demyelinating disorder of the central nervous system (CNS) with heterogeneous clinical manifestations and magnetic resonance imaging (MRI) findings. In recent years, a rare MOGAD subtype characterized by distinct clinical and MRI findings has been described. Seizures and cortical hyperintensities best seen on MRI T2-weighted fluid-attenu…

  • Beyond R&D

    Silvia Rita Sedita, Roberto Grandinetti•ARTICLE•European Planning Studies•2023

    The innovation performance of regions is increasingly dependent on the capacity of firms to rely on collaborative networks to develop new products, services, and processes. This work adopts a systemic approach to explore the collaborative innovation strategies of small and medium enterprises (SMEs), identifying the existence of multiple combinations of collaborative networks associated with high innovation performance. We conduct a configurationa…

  • Multidrug-Resistant Bacteria in Children and Adolescents with Cystic Fibrosis

    Open Access•Valentina Fainardi, Cosimo Neglia et al.•ARTICLE•Children•2022

    In patients with cystic fibrosis (CF), multidrug-resistant (MDR) bacteria can predispose to exacerbations, limit the effectiveness of antibiotic treatments and promote the progression of lung disease. The aim of this retrospective study was to compare pulmonary exacerbations (Pex), hospitalizations, lung function and nutritional status in a group of children and adolescents with CF colonized by MDR bacteria and in a noncolonized control group. Ov…

  • Prior knowledge, industry 4.0 and digital servitization. An inductive framework

    Open Access•Marco Paiola, Fausta Schiavone et al.•ARTICLE•Technological Forecasting and…•2021

  • Regional Innovation Systems or Innovative Regions? Evidence from Italy

    Open Access•Valentina De Marchi, Roberto Grandinetti•ARTICLE•Tijdschrift voor Economische en…•2017•Cited by: 1•References: 46

    The literature on regional innovation systems (RIS) has focused so far just on a few exemplary cases of regions where innovation resulted from systemic interactions between firms and institutions. This paper aims at evaluating quantitatively which regions can be considered RIS using Community Innovation Survey data on Italy. The analysis reveals a new geography of innovation in the country as compared to results emerging from studies on the 1990s…

  • Does the development of environmental innovation require different resources? Evidence from Spanish manufacturing firms

    Open Access•Giulio Cainelli, Valentina De Marchi et al.•ARTICLE•Journal of Cleaner Production•2015

  • Regional Innovation Systems or Innovative Regions? Evidence from Italy

    Open Access•Valentina De Marchi, Roberto Grandinetti•ARTICLE•Tijdschrift voor Economische en…•2017•Cited by: 1•References: 46

    The literature on regional innovation systems (RIS) has focused so far just on a few exemplary cases of regions where innovation resulted from systemic interactions between firms and institutions. This paper aims at evaluating quantitatively which regions can be considered RIS using Community Innovation Survey data on Italy. The analysis reveals a new geography of innovation in the country as compared to results emerging from studies on the 1990s…

  • Does the development of environmental innovation require different resources? Evidence from Spanish manufacturing firms

    Open Access•Giulio Cainelli, Valentina De Marchi et al.•ARTICLE•Journal of Cleaner Production•2015

  • Regional Innovation Systems or Innovative Regions? Evidence from Italy

    Open Access•Valentina De Marchi, Roberto Grandinetti•ARTICLE•Tijdschrift voor Economische en…•2017•Cited by: 1•References: 46

    The literature on regional innovation systems (RIS) has focused so far just on a few exemplary cases of regions where innovation resulted from systemic interactions between firms and institutions. This paper aims at evaluating quantitatively which regions can be considered RIS using Community Innovation Survey data on Italy. The analysis reveals a new geography of innovation in the country as compared to results emerging from studies on the 1990s…

  • Prior knowledge, industry 4.0 and digital servitization. An inductive framework

    Open Access•Marco Paiola, Fausta Schiavone et al.•ARTICLE•Technological Forecasting and…•2021

  • Multidrug-Resistant Bacteria in Children and Adolescents with Cystic Fibrosis

    Open Access•Valentina Fainardi, Cosimo Neglia et al.•ARTICLE•Children•2022

    In patients with cystic fibrosis (CF), multidrug-resistant (MDR) bacteria can predispose to exacerbations, limit the effectiveness of antibiotic treatments and promote the progression of lung disease. The aim of this retrospective study was to compare pulmonary exacerbations (Pex), hospitalizations, lung function and nutritional status in a group of children and adolescents with CF colonized by MDR bacteria and in a noncolonized control group. Ov…

  • Beyond R&D

    Silvia Rita Sedita, Roberto Grandinetti•ARTICLE•European Planning Studies•2023

    The innovation performance of regions is increasingly dependent on the capacity of firms to rely on collaborative networks to develop new products, services, and processes. This work adopts a systemic approach to explore the collaborative innovation strategies of small and medium enterprises (SMEs), identifying the existence of multiple combinations of collaborative networks associated with high innovation performance. We conduct a configurationa…

  • FLAIR Hyperintense Cortical Lesions in a 4-Year-Old Child with Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis and Seizures

    Open Access•Luca Bernardi, Nicole Mussi et al.•ARTICLE•Children•2024

    Myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease (MOGAD) is a relatively uncommon autoantibody demyelinating disorder of the central nervous system (CNS) with heterogeneous clinical manifestations and magnetic resonance imaging (MRI) findings. In recent years, a rare MOGAD subtype characterized by distinct clinical and MRI findings has been described. Seizures and cortical hyperintensities best seen on MRI T2-weighted fluid-attenu…

  • Phenotyping Pediatric Long Covid

    Open Access•Susanna Esposito, Giuseppe Maglietta et al.•ARTICLE•Children•2026

    Background: The aim of this study was to identify patient clusters based on acute symptom profiles and individual characteristics most likely to develop pediatric post-acute sequelae of SARS-CoV-2 infection (PASC), as well as clusters among patients with PASC based on post-acute sequelae and associated characteristics. Methods: This multicenter cohort study in 12 Italian pediatric units enrolled patients aged 0-17 years within three months of a l…

Business (4 works) · Computer Science (3 works) · Economics (2 works) · Industrial organization (2 works) · Knowledge management (2 works) · Marketing (2 works) · Medicine (2 works) · Antibiotics (1 works) · Asset (computer security) (1 works) · Autoimmune Neurological Disorders and Treatments (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae